A new blueprint for technology transfer
Technology transfer is a necessary evil that exists between drug development and manufacturing. But information sharing is disjointed.
Technology transfer is a necessary evil that exists between drug development and manufacturing. But information sharing is disjointed.
Come and see us at Paperless Lab Academy 2023 India. Visit our booth G8 and attend our workshop on “Managing R&D data for faster and efficient workflows with IDBS Polar platform”.
Drug sponsors and CROs must have a symbiotic relationship. Yet sponsors feel underserved by these partnerships. Is talent retention to blame?
Come and see us at Festival of Biologics in Basel. Visit our booth 604 and hear Marc Smith, Director of Strategic Solutions, speak.
Learn how to overcome manufacturing data challenges with IDBS at this year’s event in Singapore. We look forward to seeing you there!
Immunogenicity testing strategies and methodologies are well-established but we need new approaches to data handling and analysis to streamline reporting.